Literature DB >> 20462962

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

Cetin Agar1, Gwendolyn M A van Os, Matthias Mörgelin, Richard R Sprenger, J Arnoud Marquart, Rolf T Urbanus, Ronald H W M Derksen, Joost C M Meijers, Philip G de Groot.   

Abstract

The antiphospholipid syndrome is defined by the presence of antiphospholipid antibodies in blood of patients with thrombosis or fetal loss. There is ample evidence that beta(2)-glycoprotein I (beta(2)GPI) is the major antigen for antiphospholipid antibodies. The autoantibodies recognize beta(2)GPI when bound to anionic surfaces and not in solution. We showed that beta(2)GPI can exist in at least 2 different conformations: a circular plasma conformation and an "activated" open conformation. We also showed that the closed, circular conformation is maintained by interaction between the first and fifth domain of beta(2)GPI. By changing pH and salt concentration, we were able to convert the conformation of beta(2)GPI from the closed to the open conformation and back. In the activated open conformation, a cryptic epitope in the first domain becomes exposed that enables patient antibodies to bind and form an antibody-beta(2)GPI complex. We also demonstrate that the open conformation of beta(2)GPI prolonged the activated partial thromboplastin time when added to normal plasma, whereas the activated partial thromboplastin time is further prolonged by addition of anti-beta(2)GPI antibodies. The conformational change of beta(2)GPI, and the influence of the autoantibodies may have important consequences for our understanding of the antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462962     DOI: 10.1182/blood-2009-12-260976

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  71 in total

1.  Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Authors:  A Artenjak; I Locatelli; H Brelih; D M Simonič; Z Ulcova-Gallova; J Swadzba; J Musial; T Iwaniec; L Stojanovich; F Conti; G Valesini; T Avčin; J W Cohen Tervaert; Y Shoenfeld; M Blank; A Ambrožič; S Sodin-Semrl; B Božič; S Čučnik
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.

Authors:  Wenjing Zhang; Fei Gao; Donghe Lu; Na Sun; Xiaoxue Yin; Meili Jin; Yanhong Liu
Journal:  Front Med       Date:  2015-11-30       Impact factor: 4.592

3.  Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.

Authors:  D M Wahezi; N T Ilowite; X X Wu; L Pelkmans; B Laat; L E Schanberg; J H Rand
Journal:  Lupus       Date:  2013-05-20       Impact factor: 2.911

Review 4.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

5.  Platelets as pivot in the antiphospholipid syndrome.

Authors:  Philip G de Groot
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

Review 6.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

7.  Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.

Authors:  Michael R Pope; Urska Bukovnik; John M Tomich; Sherry D Fleming
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

8.  Thrombophilia Caused by Beta2-Glycoprotein I Deficiency: In Vitro Study of a Rare Mutation in APOH Gene.

Authors:  Xiao-Ping Zhang; Wei Zeng; Hui Liu; Liang Tang; Qing-Yun Wang; Zhi-Peng Cheng; Ying-Ying Wu; Bei Hu; Wei Shi; Yu Hu
Journal:  Curr Med Sci       Date:  2018-04-30

9.  Pathophysiological mechanisms in antiphospholipid syndrome.

Authors:  Brock E Harper; Rohan Wills; Silvia S Pierangeli
Journal:  Int J Clin Rheumtol       Date:  2011-04-01

Review 10.  Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

Authors:  Douglas B Cines; Keith R McCrae; X Long Zheng; Bruce S Sachais; Eline T Luning Prak; Don L Siegel
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.